Mangoceuticals (MGRX) Return on Capital Employed (2023 - 2026)
Mangoceuticals (MGRX) reported Return on Capital Employed of 112.21% for Q1 2026, down 5253.0% on a YoY basis from 2.18% in Q1 2025, and up 2.55% sequentially from 115.15% in Q4 2025.
Mangoceuticals (MGRX) Return on Capital Employed (2023 - 2026) Analysis & Trends
Mangoceuticals (MGRX) has 4 years of Return on Capital Employed data on file, last reported at 112.21% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 5253.0% year-over-year to 112.21%; the trailing twelve-month figure through Mar 2026 stood at 112.21% (down 5253.0% YoY), and the FY2025 full-year result was 121.52%, down 402.0% from the prior year.
- Return on Capital Employed advanced to 112.21% in Q1 2026, from 115.15% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 1683.96% in Q1 2024 to a low of 828.98% in Q4 2023.
- A 4-year average of 13.12% and a median of 87.02% in 2025 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed jumped 77061 bps in 2024 and plunged 174364 bps in 2025, its largest moves.
- Tracing MGRX's Return on Capital Employed over 4 years: stood at 828.98% in 2023, then jumped by 93 bps to 58.38% in 2024, then plunged by 97 bps to 115.15% in 2025, then climbed by 3 bps to 112.21% in 2026.
- Business Quant data shows MGRX's Return on Capital Employed at 112.21% in Q1 2026, 115.15% in Q4 2025, and 106.61% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.95 Bn | 24.64 Bn | 662.02 Mn | 13.00% |
| 2 | BrightSpring Health Services | 14.71 Bn | 13.81 Bn | 482.22 Mn | 7.68% |
| 3 | Healthequity | 8.35 Bn | 8.08 Bn | 256.31 Mn | 10.67% |
| 4 | 10x Genomics | 5.93 Bn | 5.39 Bn | 106.18 Mn | -4.23% |
| 5 | Hinge Health | 5.92 Bn | 5.61 Bn | 154.23 Mn | -163.65% |
| 6 | MiniMed | 4.49 Bn | 4.19 Bn | 480.00 Mn | -8.46% |
| 7 | Waystar Holding | 4.42 Bn | 4.36 Bn | 216.84 Mn | 4.73% |
| 8 | Doximity | 3.93 Bn | 3.19 Bn | 125.97 Mn | 21.81% |
| 9 | Privia Health | 3.11 Bn | 2.69 Bn | - | 4.60% |
| 10 | Mangoceuticals | 9.01 Mn | 8.82 Mn | 29,001.00 | -112.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.21% |
| Dec 31, 2025 | -115.15% |
| Sep 30, 2025 | -106.61% |
| Jun 30, 2025 | -67.42% |
| Mar 31, 2025 | -59.68% |
| Dec 31, 2024 | -58.38% |
| Sep 30, 2024 | -65.05% |
| Jun 30, 2024 | -139.31% |
| Mar 31, 2024 | 1,683.96% |
| Dec 31, 2023 | -828.98% |